Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 238

1.

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era.

Meelu OA, Mennuni MG, Theodoropoulos K, Sartori S, Baber U, Mehran R, Sharma SK, Kini AS, Dangas GD.

Hellenic J Cardiol. 2016 Aug 31. pii: S1109-9666(16)30126-9. doi: 10.1016/j.hjc.2016.08.003. [Epub ahead of print] No abstract available.

PMID:
28545912
2.

Association of altered collagen content and lysyl oxidase expression in degenerative mitral valve disease.

Purushothaman KR, Purushothaman M, Turnbull IC, Adams DH, Anyanwu A, Krishnan P, Kini A, Sharma SK, O'Connor WN, Moreno PR.

Cardiovasc Pathol. 2017 Apr 12;29:11-18. doi: 10.1016/j.carpath.2017.04.001. [Epub ahead of print]

PMID:
28453968
3.

Increased Lipid Length, Macrophage Infiltration, and Neovascularization in Coronary Atheroma From Patients With Chronic Kidney Disease.

Pena J, Vengrenyuk Y, Kezbor S, Yoshimura T, Kovacic JC, Sharma SK, Baber U, Kini AS, Narula J, Moreno PR.

JACC Cardiovasc Imaging. 2017 Apr 7. pii: S1936-878X(17)30160-2. doi: 10.1016/j.jcmg.2017.01.019. [Epub ahead of print] No abstract available.

PMID:
28412433
4.

Everolimus-Eluting Bioresorbable Scaffolds versus Metallic Everolimus-Eluting Stents: Meta-Analysis of Randomized Controlled Trials.

Sorrentino S, Giustino G, Mehran R, Kini AS, Sharma SK, Faggioni M, Farhan S, Vogel B, Indolfi C, Dangas GD.

J Am Coll Cardiol. 2017 Apr 12. pii: S0735-1097(17)37013-4. doi: 10.1016/j.jacc.2017.04.011. [Epub ahead of print]

PMID:
28412389
5.

Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.

Faggioni M, Baber U, Sartori S, Giustino G, Cohen DJ, Henry TD, Farhan S, Ariti C, Dangas G, Gibson M, Giacoppo D, Krucoff MW, Aquino M, Chandrasekhar J, Moliterno DJ, Colombo A, Vogel B, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2017 Apr 10;10(7):645-654. doi: 10.1016/j.jcin.2016.12.003. Epub 2017 Mar 15.

PMID:
28330641
6.

Assessment of trans-aortic pressure gradient using a coronary pressure wire in patients with mechanical aortic and mitral valve prostheses.

Kherada N, Brenes JC, Kini AS, Dangas GD.

Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26962. [Epub ahead of print]

PMID:
28296135
7.

A Giant Coronary Artery Aneurysm Treated With a New-Generation Drug-Eluting Stent.

Engstrom K, Khan AA, LaRocca G, Kini AS, Sharma SK.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):e65-e66. doi: 10.1016/j.jcin.2016.12.278. Epub 2017 Mar 1. No abstract available.

PMID:
28259667
8.

Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention.

Farhan S, Baber U, Vogel B, Aquino M, Chandrasekhar J, Faggioni M, Giustino G, Kautzky-Willer A, Sweeny J, Shah S, Vijay P, Barman N, Moreno P, Kovacic J, Dangas G, Kini A, Mehran R, Sharma S.

Am J Cardiol. 2017 Apr 15;119(8):1166-1172. doi: 10.1016/j.amjcard.2016.12.035. Epub 2017 Jan 25.

PMID:
28236457
9.

An Algorithm for the Use of Embolic Protection During Atherectomy for Femoral Popliteal Lesions.

Krishnan P, Tarricone A, Purushothaman KR, Purushothaman M, Vasquez M, Kovacic J, Baber U, Kapur V, Gujja K, Kini A, Sharma S.

JACC Cardiovasc Interv. 2017 Feb 27;10(4):403-410. doi: 10.1016/j.jcin.2016.12.014.

PMID:
28231909
10.

Clinical and angiographic predictors of haemodynamically significant angiographic lesions: development and validation of a risk score to predict positive fractional flow reserve.

Sareen N, Baber U, Kezbor S, Sayseng S, Aquino M, Mehran R, Sweeny J, Barman N, Kini A, Sharma SK.

EuroIntervention. 2017 Apr 7;12(18):e2228-e2235. doi: 10.4244/EIJ-D-16-00749.

PMID:
28191876
11.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators..

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

PMID:
28081827
12.

Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials.

Bavishi C, Baber U, Panwar S, Pirrotta S, Dangas GD, Moreno P, Tamis-Holland J, Kini AS, Sharma SK.

Int J Cardiol. 2017 Mar 1;230:310-318. doi: 10.1016/j.ijcard.2016.12.116. Epub 2016 Dec 27.

PMID:
28062139
13.

Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.

Li J, Volk A, Zhang J, Cannova J, Dai S, Hao C, Hu C, Sun J, Xu Y, Wei W, Breslin P, Nand S, Chen J, Kini A, Zhu J, Zhang J.

Oncotarget. 2017 Jan 31;8(5):8420-8435. doi: 10.18632/oncotarget.14220.

14.

Fibrous Cap Thickness by Optical Coherence Tomography In Vivo.

Kini AS, Vengrenyuk Y, Yoshimura T, Matsumura M, Pena J, Baber U, Moreno P, Mehran R, Maehara A, Sharma S, Narula J.

J Am Coll Cardiol. 2017 Feb 14;69(6):644-657. doi: 10.1016/j.jacc.2016.10.028. Epub 2016 Oct 29.

PMID:
27989887
15.

Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.

Kini AS, Vengrenyuk Y, Shameer K, Maehara A, Purushothaman M, Yoshimura T, Matsumura M, Aquino M, Haider N, Johnson KW, Readhead B, Kidd BA, Feig JE, Krishnan P, Sweeny J, Milind M, Moreno P, Mehran R, Kovacic JC, Baber U, Dudley JT, Narula J, Sharma S.

J Am Coll Cardiol. 2017 Feb 14;69(6):628-640. doi: 10.1016/j.jacc.2016.10.029. Epub 2016 Oct 29.

PMID:
27989886
16.

Three Dimensional Volumetric Assessment of Coronary Artery Calcification in Patients with stable Coronary Artery Disease by OCT.

Krishnamoorthy P, Vengrenyuk Y, Ueda H, Yoshimura T, Pena J, Motoyama S, Baber U, Hasan C, Kesanakurthy S, Sweeny JM, Sharma SK, Narula J, Kovacic JC, Kini AS.

EuroIntervention. 2016 Dec 15. pii: EIJ-D-16-00139. doi: 10.4244/EIJ-D-16-00139. [Epub ahead of print]

PMID:
27973330
17.

The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms.

Bahar B, Barton K, Kini AR.

Leuk Res Rep. 2016 Jul 25;6:27-28. eCollection 2016.

18.

Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention.

Theodoropoulos K, Mennuni MG, Sartori S, Meelu OA, Yu J, Baber U, Stefanini GG, Mastoris I, Moreno P, Dangas GD, Mehran R, Sharma SK, Kini AS.

EuroIntervention. 2017 Feb 20;12(14):1757-1765. doi: 10.4244/EIJ-D-15-00409.

19.

Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.

Kapadia SR, Kodali S, Makkar R, Mehran R, Lazar RM, Zivadinov R, Dwyer MG, Jilaihawi H, Virmani R, Anwaruddin S, Thourani VH, Nazif T, Mangner N, Woitek F, Krishnaswamy A, Mick S, Chakravarty T, Nakamura M, McCabe JM, Satler L, Zajarias A, Szeto WY, Svensson L, Alu MC, White RM, Kraemer C, Parhizgar A, Leon MB, Linke A; SENTINEL Trial Investigators..

J Am Coll Cardiol. 2017 Jan 31;69(4):367-377. doi: 10.1016/j.jacc.2016.10.023. Epub 2016 Nov 1.

PMID:
27815101
20.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP; EXCEL Trial Investigators..

N Engl J Med. 2016 Dec 8;375(23):2223-2235. Epub 2016 Oct 31.

PMID:
27797291

Supplemental Content

Loading ...
Support Center